Market Outlook Snapshot Market Dynamics Regional Forecast Country Insights Segment Analysis Competitive Landscape Industry News report.faq_name
On This Report

Vertebroplasty and Kyphoplasty Needles Market Size & Growth Forecast 2026–2035, By Segments (End Use, Procedure), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Report ID: FBI 11393| Published Date: Mar-2026| Format: PDF, Excel
MARKET OUTLOOK

Market Size and Growoth Outlook

Vertebroplasty and Kyphoplasty Needles Market size was around USD 944 Million in 2025 and is slated to grow at a 5% CAGR from 2026 to 2035, crossing USD 1.54 Billion by 2035. The industry revenue for 2026 is calculated at USD 984.79 million.

Base Year Value (2025)
USD 944 Million
CAGR (2026-2035)
5%
Forecast Year Value (2035)
USD 1.54 Billion
Historical Data Period
2022-2025
Largest Region
North America
Forecast Period
2026-2035

Get more details on this report

Request Free Sample Report
SNAPSHOT

Vertebroplasty and Kyphoplasty Needles Market Intelligence Snapshot

Regional Market Dynamics

  • North America held a 41.76% market share in 2025, supported by high spine procedure volumes, widespread use of minimally invasive treatments, and established hospital purchasing and clinical practices.
  • Asia Pacific is forecast to expand at a 5.7% CAGR, driven by increasing adoption of minimally invasive spinal procedures, improving hospital capabilities, and expanding access to interventional spine care.

Segment Momentum

  • Hospitals accounted for a 62.69% share in 2025 as they provide integrated imaging, specialist expertise, and perioperative support needed for vertebral compression fracture procedures and complex patient management.
  • Kyphoplasty Procedures held a 58.59% share in 2025 while recording the fastest growth due to their established role in minimally invasive vertebral fracture treatment and strong alignment with provider workflow preferences.

Market Expansion Drivers

  • Rising spinal injuries from accidents and sports increasing demand for minimally invasive fracture treatments.
  • Aging population with osteoporosis driving adoption of vertebral compression fracture procedures.
  • Expanding outpatient spine care infrastructure supporting minimally invasive spinal intervention volumes.

Leading Market Participants

FORECAST SNAPSHOT

Global Market Forecast Snapshot

Market Outlook

Prominent players in the vertebroplasty and kyphoplasty needles market include Stryker Corporation (United States), Medtronic plc (Ireland), IZI Medical Products (United States), Globus Medical, Inc. (United States), BPB Medica – Biopsybell (Italy), Teknimed S.A.S. (France), Merit Medical Systems, Inc. (United States), ZAVATION Medical Products (United States), RONTIS Corporation (Cyprus).

Regional and Segment Outlook

North America
MARKET DYNAMICS

Market Growth Drivers and Industry Trends

Rising spinal injuries from accidents and sports increasing demand for minimally invasive fracture treatments

A higher incidence of trauma-related vertebral fractures is directing more patients toward procedures that stabilize the spine quickly while limiting surgical burden, which is driving demand for the vertebroplasty and kyphoplasty needles market. In practice, clinicians treating injuries from road accidents, falls, and sports-related impacts often favor minimally invasive options when fracture morphology is suitable, as these approaches can reduce operating time, shorten hospitalization, and accelerate functional recovery. That treatment shift increases procedural throughput in trauma and spine centers, driving market development for needles designed to support precise cement delivery and controlled access to damaged vertebrae.

Aging population with osteoporosis driving adoption of vertebral compression fracture procedures

The growing pool of elderly patients with reduced bone density is steadily increasing procedure volumes that rely on specialized access and cement delivery tools, contributing to market size growth for the vertebroplasty and kyphoplasty needles market. Osteoporotic vertebral compression fractures frequently lead to persistent pain, mobility decline, and repeat clinical visits, prompting physicians to consider vertebral augmentation when conservative care does not provide adequate relief. As healthcare systems manage a larger chronic fracture burden tied to aging demographics, procurement patterns increasingly favor dependable needle systems suited to routine use in image-guided osteoporosis-related interventions.

Expanding outpatient spine care infrastructure supporting minimally invasive spinal intervention volumes

The buildout of ambulatory surgery centers, specialty spine clinics, and outpatient hospital departments is influencing market adoption by making vertebral augmentation procedures more accessible outside traditional inpatient settings. For the vertebroplasty and kyphoplasty needles market, This transition matters because outpatient providers prioritize instruments that support procedural efficiency, predictable handling, and streamlined imaging-guided workflows under tighter scheduling and cost controls. As more spine interventions move into lower-acuity care environments, purchasing expands beyond large hospitals, increasing market penetration for needle products aligned with high-turnover minimally invasive practice models.

Growth Driver Impact on CAGR Regulatory Influence Geographic Relevance Adoption Rate Impact Timeline
Rising spinal injuries from accidents and sports increasing demand for minimally invasive fracture treatments 1.80% Moderate North America, Europe High Near Term
Aging population with osteoporosis driving adoption of vertebral compression fracture procedures 1.70% High North America, Asia Pacific High Mid Term
Expanding outpatient spine care infrastructure supporting minimally invasive spinal intervention volumes 1.40% Moderate Europe, Asia Pacific Emerging Mid Term
CUSTOM RESEARCH

Unlock insights tailored to your business with our bespoke market research solutions.

Click to get your customized report now.

Request Customization →
REGIONAL FORECAST

Regional Demand Dynamics

Polymer Modified Bitumen Market
Largest Region
North America
41.76% Market Share in 2025
North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading regional position in 2025, accounting for a 41.76% share of the vertebroplasty and kyphoplasty needles market. This leadership is supported by well-established procedural volumes in spine care, broad access to image-guided interventions, and the routine use of minimally invasive treatment pathways for vertebral compression fractures across hospital and specialty settings. The region’s market activity is also supported by mature purchasing channels and clinician familiarity with standardized needle systems, which helps maintain consistent utilization in everyday practice.

Asia Pacific is projected to expand at a 5.7% CAGR over the forecast period in the vertebroplasty and kyphoplasty needles market. Growth is being propelled by the wider adoption of minimally invasive spinal procedures, improving access to interventional care, and the gradual strengthening of hospital capabilities for diagnosis and treatment of osteoporosis-related and trauma-related vertebral conditions. As more providers incorporate these procedures into regular care delivery and patient access improves across developing healthcare systems, regional demand for procedural needles continues to build.

Parameter North America Asia Pacific Europe Latin America MEA
Innovation Hub i Scale Nascent Developing Advanced
Cost-Sensitive Region i Scale Low Medium High
Regulatory Environment i Scale Restrictive Neutral Supportive
Demand Drivers i Scale Weak Moderate Strong
Development Stage i Scale Emerging Developing Developed
Adoption Rate i Scale Low Medium High
New Entrants / Startups i Scale Sparse Moderate Dense
Macro Indicators i Scale Weak Stable Strong
COUNTRY INSIGHTS

Key Country Insights

Germany 🇩🇪

Procedure Quality Emphasis

Germany prioritizes vertebroplasty and kyphoplasty needles that align with high procedural standards and specialist clinical practice. Hospitals in Germany value dependable device performance and compatibility with image-guided spine interventions.

France 🇫🇷

Specialist Spine Procedures

France maintains demand for vertebroplasty and kyphoplasty needles through specialized spinal intervention services. Healthcare facilities in France prioritize reliable procedural instruments that support efficient treatment of vertebral compression fractures.

Italy 🇮🇹

Interventional Orthopedic Support

Italy continues strengthening minimally invasive spine care through consistent adoption of vertebroplasty and kyphoplasty procedures. Hospitals in Italy focus on dependable needle systems that complement imaging-guided workflows and established orthopedic treatment practices.

Japan 🇯🇵

Elderly Spine Treatment

Japan's aging population supports continued use of vertebroplasty and kyphoplasty needles for managing osteoporotic vertebral fractures. Healthcare providers in Japan emphasize precise devices that facilitate efficient minimally invasive spinal procedures.

South Korea 🇰🇷

Advanced Imaging Integration

South Korea favors vertebroplasty and kyphoplasty needles designed for accurate placement within image-guided interventional procedures. Spine specialists in South Korea continue adopting technologies that support procedural consistency and patient-focused treatment pathways.

United States 🇺🇸

Minimally Invasive Spine Care

The U.S. market emphasizes vertebroplasty and kyphoplasty needles that support minimally invasive treatment of vertebral compression fractures. Healthcare providers in the U.S. continue adopting specialized procedural tools that improve precision and procedural efficiency.

SEGMENT ANALYSIS

Segment Leadership and Growth Trends

Vertebroplasty and Kyphoplasty Needles Market Share (%), End Use, 2025

Hospitals
Ambulatory Surgical Centers

Go beyond the chart, access full insights & data tables

Request Free Sample Report
End Use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals held the strongest position in the vertebroplasty and kyphoplasty needles market in 2025, accounting for a 62.69% share. This leadership is underpinned by the hospital setting’s ability to manage vertebral compression fracture cases that require integrated imaging access, specialist intervention, and broader perioperative support. In practice, hospitals remain the primary site for these procedures because they are better equipped to handle more complex patient profiles and maintain the procedural infrastructure needed for consistent use of vertebroplasty and kyphoplasty needles.

Ambulatory Surgical Centers are emerging as the fastest-growing end-use segment in the vertebroplasty and kyphoplasty needles market as providers increasingly favor care settings that support procedural efficiency and streamlined patient flow. Their momentum is tied to the suitability of selected minimally invasive spine procedures for outpatient environments, where faster scheduling and lower operational intensity can make treatment delivery more practical. Compared with traditional inpatient-oriented settings, Ambulatory Surgical Centers are seeing wider adoption as more case volumes shift toward controlled, lower-complexity interventions.

Procedure Segment Analysis: Kyphoplasty Procedures (Largest & Fastest-Growing Segment)

With a 58.59% share in 2025, Kyphoplasty Procedures led the vertebroplasty and kyphoplasty needles market while also recording the fastest growth within the procedure segment. Their combined strength reflects the procedure’s established role in treating vertebral compression fractures in settings where controlled cavity creation and cement delivery are central to procedural workflow. Continued growth is being supported by sustained clinical adoption patterns and the practical fit of kyphoplasty with provider preferences for structured, minimally invasive spinal intervention, which keeps demand for vertebroplasty and kyphoplasty needles closely tied to this procedure type.

Segment Sub-Segment Largest Segment Fastest Growing
End Use Hospitals, Ambulatory Surgical Centers Hospitals Ambulatory Surgical Centers
Procedure Kyphoplasty Procedures, Vertebroplasty Procedures, Directional Vertebroplasty Needles, Straight Vertebroplasty Needles Kyphoplasty Procedures Kyphoplasty Procedures
Competitive Landscape

Competitive Landscape and Market Positioning

Leading companies in the vertebroplasty and kyphoplasty needles market:

1. Stryker Corporation (United States)

2. Medtronic plc (Ireland)

3. IZI Medical Products (United States)

4. Globus Medical Inc. (United States)

5. BPB Medica – Biopsybell (Italy)

6. Teknimed S.A.S. (France)

7. Merit Medical Systems Inc. (United States)

8. ZAVATION Medical Products (United States)

9. RONTIS Corporation (Cyprus)

The vertebroplasty and kyphoplasty needles market is witnessing advancements in minimally invasive spinal treatment technologies and precision-guided procedural tools. Manufacturers are developing ergonomically optimized needle systems that improve accuracy, handling, and patient outcomes during vertebral augmentation procedures. Increasing prevalence of osteoporosis-related spinal disorders is further contributing to market expansion.

Company Market Share Company Revenue Revenue CAGR (%) Product Portfolio Geographic Presence Innovation / R&D Focus Strategic Developments
No companies available.
🔒 This section is available as a standalone purchase. Buy only the data you need. Inquire Before Buying
Industry News

Industry Development/News

Company Name Date Key Development
Stryker Aug-24 Stryker signed a definitive agreement to acquire Vertos Medical, a specialist in minimally invasive spine solutions. This acquisition is designed to integrate the "mild" procedure for lumbar spinal stenosis into Stryker's interventional spine portfolio, offering a comprehensive suite of solutions for chronic back pain management.
IZI Medical Products Aug-21 IZI Medical Products launched Vertefix HV, a high-viscosity bone cement featuring proprietary "Insite" tracking beads. This product innovation provides surgeons with real-time visualization of cement flow during vertebroplasty and kyphoplasty, enhancing procedural safety and accuracy in stabilizing vertebral fractures.
Report Customization

Explore This Report

Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.

1 report.custom report.segments 2 Custom TOC 3 Related Reports

Vertebroplasty and Kyphoplasty Needles Market — Custom Segments

Segment Sub-Segment
No segment data available.

Vertebroplasty and Kyphoplasty Needles Market — report.custom

Custom Chapter Custom Details
No custom TOC data available.

Need a different cut of the data?

Request Custom Research
report.faq_name

What is the market valuation of vertebroplasty and kyphoplasty needles?

The market size of the vertebroplasty and kyphoplasty needles is estimated at USD 984.79 million in 2026.

How is the vertebroplasty and kyphoplasty needles industry size expected to evolve during the forecast period?

Vertebroplasty and Kyphoplasty Needles Market size is forecasted to reach USD 1.54 billion by 2035 rising from USD 944 million in 2025 at a CAGR of more than 5% between 2026 and 2035.

How are rising trauma-related spinal injuries influencing demand in the vertebroplasty and kyphoplasty needles market?

Growing incidence of accident and sports-related vertebral fractures is increasing preference for minimally invasive stabilization procedures that reduce operating time, shorten hospitalization, and improve functional recovery outcomes in trauma care.

Why is outpatient spine care expansion increasing adoption of vertebroplasty and kyphoplasty needle systems?

Growth of ambulatory surgery centers and specialty spine clinics is driving demand for needle systems that support efficient image-guided procedures with predictable handling and streamlined workflows under tight scheduling constraints.

Why are hospitals the largest end users of vertebroplasty and kyphoplasty needles?

Hospitals accounted for a 62.69% share in 2025 as they provide integrated imaging, specialist expertise, and perioperative support needed for vertebral compression fracture procedures and complex patient management.

Why are Kyphoplasty Procedures the fastest-growing procedure segment in the vertebroplasty and kyphoplasty needles market?

Kyphoplasty Procedures held a 58.59% share in 2025 while recording the fastest growth due to their established role in minimally invasive vertebral fracture treatment and strong alignment with provider workflow preferences.

Why does North America lead the vertebroplasty and kyphoplasty needles market?

North America held a 41.76% market share in 2025, supported by high spine procedure volumes, widespread use of minimally invasive treatments, and established hospital purchasing and clinical practices.

Which region is projected to grow fastest in the vertebroplasty and kyphoplasty needles market?

Asia Pacific is forecast to expand at a 5.7% CAGR, driven by increasing adoption of minimally invasive spinal procedures, improving hospital capabilities, and expanding access to interventional spine care.

Which companies dominate the vertebroplasty and kyphoplasty needles landscape?

Prominent players in the vertebroplasty and kyphoplasty needles market include Stryker Corporation (United States), Medtronic plc (Ireland), IZI Medical Products (United States), Globus Medical, Inc. (United States), BPB Medica – Biopsybell (Italy), Teknimed S.A.S. (France), Merit Medical Systems, Inc. (United States), ZAVATION Medical Products (United States), RONTIS Corporation (Cyprus).
Testimonials

Our Clients

"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."

Quality Assurance Manager

"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."

R&D Manager

"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."

Senior Marketing Manager
THE RESEARCH BEHIND THIS REPORT

Our Research Team & Methodology

Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.

THIS REPORT'S RESEARCH VERTICAL

Research Team Overview

♢
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.

Prepared by the Healthcare & Medical Devices Research Team

10+
Industry Verticals
100+
Countries Analyzed
5–7
Days Standard
Delivery
12k+
Research Reports
Published
On-
Demand
Customized Research
Available
6
Months Analyst
Support
PDF + XLS
Report Deliverables

Trust & Compliance

☷D&B D-U-N-S
♢GDPR & CCPA Compliant
♙ISO 9001 Certified (ISO 9001:2015)
♙SSL Encryption
▭Secure Payments
✓Confidential Handling

Research Domains

10 coverage areas
Medical Devices & Equipment Diagnostic Imaging Clinical Diagnostics Digital Health & Telemedicine Patient Monitoring Systems Surgical & Minimally Invasive Technologies Healthcare IT & Data Systems Biotechnology & Life Sciences Pharmaceutical Technologies Healthcare Delivery & Services

Research Intelligence

Executive Leadership
Product & Technology Experts
Manufacturing & Operations Leaders
Procurement & Supply Chain Professionals
Sales & Commercial Executives
Channel Partners & Distribution Networks
Enterprise Buyers & End Users
Industry Consultants & Regulatory Experts

Research Workflow & Quality Assurance

📥
01

Data Collection

Verified information gathered through primary and secondary research.

🔍
02

Data Triangulation

Cross-validation using multiple independent data sources.

📈
03

Forecast Modelling

Market estimates developed using historical trends and analytical models.

👨‍💼
04

Analyst Validation

Findings reviewed by domain experts for accuracy and consistency.

📝
05

Editorial & Quality Review

Final editorial, quality, and compliance checks before publication.

✅
06

Final Publication

Released after successful completion of the internal review process.

Report Coverage

📊 Market Assessment

  • Market Size & Forecast
  • Market Segmentation
  • Regional Analysis
  • Growth Drivers & Challenges
  • Market Dynamics

🏢 Competitive Intelligence

  • Competitive Landscape
  • Company Profiles
  • Competitive Benchmarking
  • Mergers & Acquisitions
  • Market Share Analysis or Key Company Strategies

🔍 Strategic Analysis

  • Value Chain Analysis
  • Porter's Five Forces
  • PESTLE Analysis
  • Pricing Trends
  • Supply-Demand Analysis

🚀 Future Outlook

  • Technology Landscape
  • Regulatory Landscape
  • Investment & Funding Landscape
  • Emerging Opportunities
  • Future Market Outlook

Have a question about this report or need a custom scope?

Request Customization
License

Select License Type

Single User
US$ 4,250
Buy Now
Corporate User
US$ 6,150
Buy Now

Want this data scoped to your exact question?

Tell us the segments, regions, or competitors you need answered — an analyst will confirm scope before any custom work starts.

Talk to an Analyst →